ANI Pharmaceuticals, Inc.ANIPNASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+32.8%
5Y CAGR+29.4%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+32.8%/yr
vs +22.9%/yr prior
5Y CAGR
+29.4%/yr
Recent acceleration
Acceleration
+9.9pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
3.6x
Strong expansion
Streak
9 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $499.10M | +37.3% |
| 2024 | $363.58M | +40.7% |
| 2023 | $258.33M | +21.3% |
| 2022 | $212.88M | +37.1% |
| 2021 | $155.32M | +13.1% |
| 2020 | $137.33M | +8.1% |
| 2019 | $127.04M | +36.3% |
| 2018 | $93.19M | +35.9% |
| 2017 | $68.58M | +29.2% |
| 2016 | $53.08M | - |